Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06353893 · ClinicalTrials.gov registry record

MRI Evaluation of Integrity Implant for Rotator Cuff Tears

A clinical trial of Rotator Cuff Tears, sponsored by Foundation for Orthopaedic Research and Education.

Active
Registry status
20
Enrollment target
1
Study location

NCT06353893: Active study of Rotator Cuff Tears, sponsored by Foundation for Orthopaedic Research and Education.

NCT06353893 is a study of Rotator Cuff Tears that is active but no longer recruiting, run by Foundation for Orthopaedic Research and Education. The registered enrollment target is 20 participants, below the 1,280-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06353893, a study of Rotator Cuff Tears, is active but no longer recruiting, sponsored by Foundation for Orthopaedic Research and Education.

ACTIVE NOT RECRUITING
Registry status
20 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to evaluate the effectiveness and safety of the Integrity bio-inductive implant in treating partial and full thickness rotator cuff tears. The main questions it aims to answer are: * How does the application of the Integrity implant affect patient-reported outcome measures (PROMs) such as ASES, SANE, and PROMIS? * What are the imaging characteristics of the rotator cuff tears at 3 and 6 months postoperatively when using the Integrity implant? Postoperative MRIs will be obtained from 10 consecutive patients who have undergone rotator cuff repair using the Integrity implant at 3 and 6 months after surgery. Participants include those with partial and full thickness tears treated with different surgical techniques involving the implant. They may receive either isolated onlay use of the graft for partial tears or augmentation of a standard single or double row repair with the graft applied to the superior surface of the repair.

Primary Outcome

The primary endpoint of this study is the adverse events rate and structural failure rate of the rotator cuff repair, determined by MRI, at 3 months and 6 months following use of the Anika Integrity implant system.

Conditions Studied

Interventions

  • DEVICE Anika Integrity Implant System

Study Locations (1)

Florida

  • Foundation for Orthopaedic Research and Education - Tampa

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-04-01
Est. Completion 2026-05-01

What the registry record for NCT06353893 still lists

NCT06353893 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,280-participant average among 20 other Rotator Cuff Tears trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Rotator Cuff Tears appearing as the primary indexed condition, and to 1 intervention - of which Anika Integrity Implant System is the first listed.

NCT06353893 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06353893 about?

NCT06353893 is a clinical study titled "MRI Evaluation of Integrity Implant for Rotator Cuff Tears". The goal of this observational study is to evaluate the effectiveness and safety of the Integrity bio-inductive implant in treating partial and full thickness rotator cuff tears. The main questions it aims to answer are: * How does the application of the Integrity implant affect patient-reported ou...

What is the current status of trial NCT06353893?

This trial is currently active not recruiting. The enrollment target is 20 participants. The study started on 2024-04-01. Estimated completion is 2026-05-01.

What conditions does trial NCT06353893 study?

This clinical trial studies the following conditions: Rotator Cuff Tears.

What interventions are being tested in trial NCT06353893?

The interventions under investigation include: Anika Integrity Implant System (DEVICE).

Who is sponsoring clinical trial NCT06353893?

This trial is sponsored by Foundation for Orthopaedic Research and Education, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06353893 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rotator Cuff Tears

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06353893's enrollment target sits among peer trials

20 20th of 20 the lowest of 20 other Rotator Cuff Tears trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rotator Cuff Tears trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06353893, the US trial registry maintained by the National Library of Medicine. NCT06353893 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.